Letter to the editor: Readers response to "Predicted long-term antibody persistence for a tick-borne encephalitis vaccine: results from a modeling study beyond 10 years after a booster dose following different primary vaccination schedules"
Hum Vaccin Immunother
.
2020 Sep 1;16(9):2280-2281.
doi: 10.1080/21645515.2020.1783954.
Epub 2020 Jul 23.
Authors
Farid Khan
1
,
Xingbin Wang
1
,
Bing Cai
1
,
Wilhelm Erber
2
,
Heinz-J Schmitt
3
Affiliations
1
Pfizer Vaccines , Collegeville, PA, USA.
2
Pfizer Vaccines , Vienna, Austria.
3
Pfizer Vaccines , Berlin, Germany.
PMID:
32701398
PMCID:
PMC7560906
DOI:
10.1080/21645515.2020.1783954
No abstract available
Publication types
Letter
Comment
MeSH terms
Encephalitis Viruses, Tick-Borne* / immunology
Encephalitis, Tick-Borne* / prevention & control
Humans
Immunization, Secondary
Vaccination
Vaccines*
Substances
Vaccines